“PROMETRIKA acts as an agile and synergistic extension of your team for clinical trials. We provide the leadership and trial oversight that seamlessly streamlines communication, ensures regulatory compliance, prevents delays, and can minimize costs. We’ve collaborated on over 1,000 phase 1 to phase 4 clinical trials and achieved new drug approvals by the U.S. FDA and European regulatory agencies. Well-versed in studies of all therapeutic areas, we have specialized expertise in rare disease and oncology clinical trials.”